CollPlant Biotechnologies (CLGN) Other Gross PP&E Adjustments (2018 - 2025)
Historic Other Gross PP&E Adjustments for CollPlant Biotechnologies (CLGN) over the last 8 years, with Q2 2025 value amounting to -$2.7 million.
- CollPlant Biotechnologies' Other Gross PP&E Adjustments rose 1983.52% to -$2.7 million in Q2 2025 from the same period last year, while for Sep 2025 it was -$1.5 million, marking a year-over-year increase of 9995.27%. This contributed to the annual value of $6.3 million for FY2024, which is 2393.18% up from last year.
- Per CollPlant Biotechnologies' latest filing, its Other Gross PP&E Adjustments stood at -$2.7 million for Q2 2025, which was up 1983.52% from -$2.8 billion recorded in Q1 2025.
- In the past 5 years, CollPlant Biotechnologies' Other Gross PP&E Adjustments registered a high of $6.3 million during Q4 2024, and its lowest value of -$2953.0 billion during Q4 2021.
- Its 5-year average for Other Gross PP&E Adjustments is -$165.0 billion, with a median of -$3.4 million in 2023.
- Its Other Gross PP&E Adjustments has fluctuated over the past 5 years, first tumbled by 10588010211.55% in 2021, then surged by 10018.88% in 2023.
- Over the past 5 years, CollPlant Biotechnologies' Other Gross PP&E Adjustments (Quarter) stood at -$2953.0 billion in 2021, then surged by 99.91% to -$2.7 billion in 2022, then surged by 100.19% to $5.1 million in 2023, then rose by 23.93% to $6.3 million in 2024, then plummeted by 143.08% to -$2.7 million in 2025.
- Its Other Gross PP&E Adjustments was -$2.7 million in Q2 2025, compared to -$2.8 billion in Q1 2025 and $6.3 million in Q4 2024.